Sintetica SA: Clinical Trials

11 trials sponsored by Sintetica SA, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed, 1 terminated. 6 Phase 2, 5 Phase 3, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 26Completed 6
Phase 35Completed 4, Terminated 1
Phase 12Completed 2

Follow Sintetica SA: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Chloroprocaine 3% Gel and Oxybuprocaine 0.4% Eye Drops Anesthesia in Pediatric Population
Chloroprocaine 3% eye gel, Oxybuprocaine Hydrochloride 4 Mg/mL Eye Drops - Local Anesthetic
Phase 3CompletedSintetica SA742024-05-232026-03-09
Chloroprocaine 3% Gel Eye Drop as Topical Anestheticsin Phacoemulsification.
Chloroprocaine 3%, Tetracaine 0.5% - Cataract
Phase 3CompletedSintetica SA3382020-09-092023-01-18
Efficacy, Safety and Tolerability Study of Chloroprocaine 3% Gel Eye Drops in Healthy Volunteers
Ocular gel - Healthy Volunteers
Phase 2 / Phase 3CompletedSintetica SA962020-06-292022-03-17
Efficacy, Safety and Local Tolerability Study of Chloroprocaine 3% Gel Eye Drops in Healthy Volunteers
Ocular gel - Healthy Subjects
Phase 1 / Phase 2CompletedSintetica SA1052020-06-162021-09-16
The Efficacy and Safety of Chloroprocaine 1% and 2% in Pediatric Population
Chloroprocaine 1% Injectable Solution, Chloroprocaine 2% Injectable Solution - Hernia, Inguinal, Flat Foot
Phase 2CompletedSintetica SA1642019-02-142026-03-23
Intrathecal Paracetamol Before Spinal Anaesthesia With Chloroprocaine HCl 1% for Short Knee Procedures
30 mg Paracetamol 3% (1 mL), 60 mg Paracetamol 3% (2 mL), 90 mg Paracetamol 3% (3 mL) - Pain, Postoperative
Phase 2CompletedSintetica SA602018-08-062021-06-24
Dose-finding Study of Intrathecal Paracetamol Administered Immediately Before Spinal Anaesthesia
Paracetamol 3%, Placebo injection containing Saline solution 0.9%, Hyperbaric Bupivacaine HCl 0.5% - Phase 1: Pain Management, Phase 2: Pain Management
Phase 1 / Phase 2CompletedSintetica SA692016-11-012021-10-27
Chloroprocaine 3% - Epidural Anesthesia in Unplanned Caesarean Section
Chloroprocaine, Ropivacaine - Unplanned Caesarean Section
Phase 3TerminatedSintetica SA162016-10-012023-11-21
Spinal Anaesthesia With Chloroprocaine HCl 1% for Elective Lower Limb Procedures of Short Duration.
Chloroprocaine HCl 1% - Short Duration Lower Limb Surgery Via Spinal Anaesthesia
Phase 2CompletedSintetica SA452015-06-012021-05-18
Chloroprocaine 2% vs Ropivacaine 0.75% in Ultrasound-guided Axillary Nerve Block
Chloroprocaine HCl 2%, Ropivacaine 0.75% - Axillary Nerve Block
Phase 3CompletedSintetica SA2112015-04-012021-07-15
Observational Study on 2-chloroprocaine Hydrochloride 1%
2-chloroprocaine hydrochloride, 1% - Neurological Complication, in Particular TNS or CES
CompletedSintetica SA3942013-11-012021-06-29

Conditions studied

Cataract (1)  ·  Flatfoot (1)  ·  Hernia, Inguinal (1)  ·  Pain, Postoperative (1)  ·  Schmid-Fraccaro syndrome (1)

Interventions

chloroprocaine (3)  ·  Ropivacaine (2)  ·  3-(cystein-S-yl)paracetamol (1)  ·  Acetaminophen (1)  ·  DMAC2L protein, human (1)  ·  Injections (1)  ·  Ophthalmic Solutions (1)  ·  Saline Solution (1)  ·  Solutions (1)  ·  benoxinate (1)

Countries

Italy (4)  ·  Switzerland (4)  ·  Belgium (2)  ·  Spain (2)  ·  Austria (1)  ·  Slovakia (1)

Top investigators

Claudio Camponovo, MD (3)  ·  Andrea Saporito, MD (1)  ·  Capdevila Xavier, MD (1)  ·  Gerhard Garhoefer (1)  ·  Guido Fanelli, MD (1)  ·  Holger Sauer, MD (1)  ·  John Van Delft, MD (1)  ·  Jorge Alio, MD (1)  ·  Laurent Delaunay, MD (1)  ·  Marc Van de Velde, MD (1)  ·  Martin Bauer, MD (1)  ·  Milko Radicioni (1)  ·  Oliver Kimberger, Prof (1)  ·  Stefano Bonarelli, MD (1)  ·  Stefano MD Bonarelli (1)

Results publications

PMID 33610175, PMID 33976374, PMID 38489057

NIH funding

2014 (1)